Du är här


INC RESEARCH, LLC: INC Research Announces Partnership with Society for Clinical Research Sites

Partnership reinforces sites' pivotal role in clinical development,
Company's on-going commitment to fostering strong site relationships globally

Raleigh, N.C.,
May 27, 2014 -INC Research, a leading, global Phase I to IV clinical research
organization (CRO), today announced a two-year partnership with the Society
for Clinical Research Sites (SCRS), the first and only global trade
organization fully dedicated to representing the interests of clinical
research sites. The Company will participate as a Global Impact Partner
(GIP), the highest level of membership within SCRS. This move further
underscores INC's continued focus on and commitment to this key stakeholder
group, which plays a pivotal role in bringing new therapies to market.

"We're excited to become an active voice in a community that fully recognizes
and supports the critical role of sites in the clinical development process,"
said INC Research CEO Jamie Macdonald. "Developing and maintaining quality
relationships with investigative sites around the world is a critical success
factor to accelerating the delivery of new medicines to market. Joining SCRS
is one more way INC Research can demonstrate our commitment to sites by
actively collaborating with industry stakeholders on initiatives aimed at
establishing best site practices."

"SCRS is proud to partner with INC Research," said SCRS President, Christine
Pierre. "Collaboration with leading organizations across the clinical
research landscape is a pivotal strategic platform for SCRS. This commitment
by INC Research speaks to their strong desire to better understand the sites'
perspective, hear their voice and grow closer to the core of the research

As a Global Impact Partner (GIP), INC will participate on the SCRS Global
Impact Board at an executive level. Working in tandem with SCRS' Leadership
Council, the Board helps set strategic initiatives for the Society, which
advocates, connects, educates, and mentors more than 1,400 sites represented
across 22 countries. By providing its members the ability to participate in
discussions and decisions, the organization helps to give sites a stronger,
more credible voice and a shared purpose within the global clinical research

INC Research is focused on connecting customers, sites and patients to improve
world health. Ranked the "Top CRO to Work with" in the 2013 CenterWatch
Global Investigative Site Relationship Survey of more than 2,000 sites
globally, the Company is committed to developing and nurturing deep site
relationships that ensure rapid study start-up, smooth study conduct and
consistently excellent results. For more information, see ourSite
Relationshipsfact sheet.

About SCRS
SCRS is a global trade organization founded in 2012 and represents over 1,400
research sites, including 13,000 Investigators and 12,000 research staff in
22 countries. SCRS' mission is to unify and amplify the voice of the global
clinical research site community for site sustainability. SCRS has become an
active partner in industry-wide initiatives and dialogues focused on
improving the clinical research enterprise. Sites, as well as companies that
sponsor or support the work conducted at the clinical research sites, will
benefit from membership and partnership. VisitMySCRS.org.

About INC Research
INC Research is a leading, global full-service clinical research organization
(CRO) providing the full range ofPhase I to IV clinical development
servicesfor the world's pharmaceutical, biotech and medical device
industries. As a therapeutically focused CRO, with aTrusted Process®delivery
methodology, developing the medicines people need is something we take
personally. Leveraging the breadth of our service offerings and the depth of
ourtherapeutic expertiseacross multiple patient populations,INC Research
connectscustomers, investigative sites and patients to accelerate the
delivery of new medicines to market to improve world health. We were ranked
"Top CRO to Work With" by sites worldwide in the 2013 CenterWatch Global
Investigative Site Relationship Survey. INC Research is headquartered in
Raleigh, NC, with operations across six continents and experience spanning
more than 100 countries. For more information, please
visitwww.incresearch.comand connect with us onLinkedInand

Lori Dorer, Media +1 (513) 345-1685


This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: INC RESEARCH, LLC via Globenewswire


Författare Hugin

Tala om vad ni tycker

Tala om vad ni tycker

Ni är just nu inne på en betaversion av nya aktiespararna. Lämna gärna feedback på vad ni tycker i formuläret nedan.